ALPS Advisors’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-19,392
| Closed | -$256K | – | 1056 |
|
|
2025
Q1 | $256K | Sell |
19,392
-1,158
| -6% | -$15.3K | ﹤0.01% | 945 |
|
|
2024
Q4 | $368K | Buy |
+20,550
| New | +$368K | ﹤0.01% | 748 |
|
|
2021
Q4 | – | Sell |
-4,702
| Closed | -$587K | – | 962 |
|
|
2021
Q3 | $587K | Sell |
4,702
-268
| -5% | -$33.5K | 0.01% | 482 |
|
|
2021
Q2 | $623K | Sell |
4,970
-1,545
| -24% | -$194K | 0.01% | 490 |
|
|
2021
Q1 | $884K | Buy |
6,515
+120
| +2% | +$16.3K | 0.01% | 411 |
|
|
2020
Q4 | $581K | Buy |
+6,395
| New | +$581K | 0.01% | 479 |
|
|
2018
Q2 | – | Sell |
-999
| Closed | -$305K | – | 965 |
|
|
2018
Q1 | $305K | Buy |
999
+174
| +21% | +$53.1K | ﹤0.01% | 815 |
|
|
2017
Q4 | $243K | Buy |
+825
| New | +$243K | ﹤0.01% | 776 |
|